No Picture
News

Indapta Therapeutics to Highlight its g-NK Cell Platform for the Treatment of Cancer and Autoimmune Disease in a Plenary Session at New York Academy of Sciences Frontiers in Cancer Immunotherapy Conference

HOUSTON & SEATTLE–(BUSINESS WIRE)–Indapta Therapeutics, Inc., a privately held biotechnology company developing differentiated cell therapies for the treatment of cancer and autoimmune diseases, announced that CEO Mark Frohlich, MD, will be giving a plenary talk […]

[adinserter block="3"]
[adinserter block="3"]
No Picture
News

Coya Therapeutics Announces the Completion of a Controlled Phase 2 Study of Low Dose Interleukin-2 (LD IL-2) in Patients with Alzheimer’s Disease

HOUSTON–(BUSINESS WIRE)–Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, announces the completion of a randomized, double-blind, placebo-controlled Phase 2 study […]

News

Overlake agrees to affiliation with MultiCare system

Under the agreement, Bellevue-based Overlake and its clinics will become the flagship of MultiCare’s new North Sound region. Click here to view original post Click Here to Publish/Feature Your Company or Product News with Biotech […]

[adinserter block="3"]
News

Overlake and MultiCare Sign Affiliation Agreement

Agreement includes continued local governance and management, ongoing community commitment and significant capital investment in the region. TACOMA, Wash., May 21, 2024 /PRNewswire/ — Overlake Medical Center & Clinics and MultiCare Health System announced today […]